SUBSCRIBE
SUBSCRIBE

Bioheart, Inc. Announces Commercial Order for TGI 1200(tm) Adult Stem Cell Isolation System for Use in Chronic Limb Ischemia Patients

January 14, 2009 | 
1 min read

SUNRISE, Fla., Jan. 14, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) announced today it has received a purchase order for a TGI 1200 System from Philadelphia BioMed Product Development Centre.*